Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-7.44%
Price
26.07.24
€1.51
Summary
This prediction is currently active. With a performance of -7.44%, the BUY prediction for Ocugen Inc. by BiotechBee is down slightly. This prediction currently runs until 28.02.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocugen Inc. | -1.633% | -1.633% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocugen Inc. diskutieren
Buy mit Kursziel 3,5